Bristol Myers Squibb (NYSE: BMY; BMS) beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on which BMS is counting on for ...
Old stereo gear doesn't have to collect dust. From streaming upgrades to smarter home setups, there are practical ways to ...